PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
411,000
-1,500 (-0.36%)
At close: Dec 4, 2025
87.24%
Market Cap4.27T
Revenue (ttm)496.03B
Net Income (ttm)151.24B
Shares Out10.39M
EPS (ttm)14,561.81
PE Ratio28.22
Forward PE19.20
Dividend1,100.00 (0.27%)
Ex-Dividend DateDec 29, 2025
Volume186,676
Average Volume196,227
Open412,000
Previous Close412,500
Day's Range396,500 - 412,000
52-Week Range201,500 - 713,000
Beta0.50
RSI39.61
Earnings DateNov 11, 2025

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 450
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.